Genetic and Environmental Factors in the Response to Influenza Vaccination
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine Blish, MD
Stanford School of Medicine, Dept. of Medicine
Principal Investigator - Cornelia Dekker, MD
Stanford School of Medicine, Dept. of Pediatrics
Principal Investigator - Mark M Davis, PhD
Stanford School of Medicine, Dept. of Microbiology and Immunology
Principal Investigator - William Robinson, MD
Stanford School of Medicine, Dept. of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Stanford, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Oct 2014
- Primary completion
- 12 Dec 2018
- Completion
- 12 Dec 2018
- Last update posted
- 13 Feb 2020
- Registered enrollment
- 109
- Registry id
- NCT03088904
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.